what is the most performance mid stock between january 30 2023 and march 1 2023

MoonLake Immunotherapeutics (MLTX) had the highest return between January 30, 2023 and March 1, 2023 by a mid-cap US stock, returning 66.9%.

ASSET DATE % RETURN
MoonLake Immunotherapeutics (MLTX)
1/30/2023 - 3/1/2023
66.94%
SoundHound AI (SOUN)
1/30/2023 - 3/1/2023
53.26%
Oscar Health (OSCR)
1/30/2023 - 3/1/2023
51.64%
VEON (VEON)
1/30/2023 - 3/1/2023
47.27%
Intapp (INTA)
1/30/2023 - 3/1/2023
37.26%
Vita Coco (COCO)
1/30/2023 - 3/1/2023
34.3%
Frontline (FRO)
1/30/2023 - 3/1/2023
34.2%
Viking Therapeutics (VKTX)
1/30/2023 - 3/1/2023
32.91%
Iris Energy (IREN)
1/30/2023 - 3/1/2023
32.37%
Merus (MRUS)
1/30/2023 - 3/1/2023
32.2%
Goosehead Insurance (GSHD)
1/30/2023 - 3/1/2023
31.27%
Lantheus (LNTH)
1/30/2023 - 3/1/2023
30.94%
ELF Beauty (ELF)
1/30/2023 - 3/1/2023
30.73%
ZIM Integrated Shipping Services (ZIM)
1/30/2023 - 3/1/2023
29.95%
Scorpio Tankers (STNG)
1/30/2023 - 3/1/2023
28.1%
Nextdecade (NEXT)
1/30/2023 - 3/1/2023
27.64%
Scotts Miracle-Gro (SMG)
1/30/2023 - 3/1/2023
27.44%
BridgeBio Pharma (BBIO)
1/30/2023 - 3/1/2023
25.72%
MYR (MYRG)
1/30/2023 - 3/1/2023
25.65%
Allegro Microsystems  (ALGM)
1/30/2023 - 3/1/2023
25.24%
Miniso Group Holding  (MNSO)
1/30/2023 - 3/1/2023
24.01%
Appfolio (APPF)
1/30/2023 - 3/1/2023
23.73%
Weatherford International (WFRD)
1/30/2023 - 3/1/2023
23.58%
Palomar (PLMR)
1/30/2023 - 3/1/2023
23.42%
AAON (AAON)
1/30/2023 - 3/1/2023
22.28%
Mid-cap stocks are treated as having a market cap between $2B and $10B.